Form 8-K - Current report:
SEC Accession No. 0001213900-25-040724
Filing Date
2025-05-07
Accepted
2025-05-07 17:18:13
Documents
17
Period of Report
2025-05-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241155-8k_adial.htm   iXBRL 8-K 38471
2 FORM OF SERIES B-1 WARRANT ea024115501ex4-1_adial.htm EX-4.1 92191
3 FORM OF SERIES C-1 WARRANT ea024115501ex4-2_adial.htm EX-4.2 93068
4 FORM OF WARRANT INDUCEMENT AGREEMENT BY AND BETWEEN ADIAL PHARMACEUTICALS, INC. ea024115501ex10-1_adial.htm EX-10.1 71067
5 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MAY 2, 2025 ea024115501ex99-1_adial.htm EX-99.1 11686
  Complete submission text file 0001213900-25-040724.txt   557584

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20250502.xsd EX-101.SCH 3005
7 XBRL LABEL FILE adil-20250502_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE adil-20250502_pre.xml EX-101.PRE 22352
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0241155-8k_adial_htm.xml XML 3657
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 25922758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)